These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6150945)

  • 1. Do beta blockers differ in their effects on hepatic microsomal enzymes and liver blood flow?
    Parker G; Ene MD; Daneshmend TK; Roberts CJ
    J Clin Pharmacol; 1984; 24(11-12):493-9. PubMed ID: 6150945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of four beta-blockers as assessed by 24-hour ECG recording.
    Escoubet B; Leclercq JF; Maison-Blanche P; Poirier JM; Gourmel B; Delhotal-Landes B; Coumel P
    Clin Pharmacol Ther; 1986 Apr; 39(4):361-8. PubMed ID: 3956052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of beta-adrenoceptor antagonists on the pharmacokinetics of rizatriptan, a 5-HT1B/1D agonist: differential effects of propranolol, nadolol and metoprolol.
    Goldberg MR; Sciberras D; De Smet M; Lowry R; Tomasko L; Lee Y; Olah TV; Zhao J; Vyas KP; Halpin R; Kari PH; James I
    Br J Clin Pharmacol; 2001 Jul; 52(1):69-76. PubMed ID: 11453892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of antipyrine metabolism by beta-adrenoceptor antagonists.
    Bax ND; Lennard MS; Tucker GT
    Br J Clin Pharmacol; 1981 Dec; 12(6):779-84. PubMed ID: 6122461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of four beta-adrenoceptor antagonists during modest exercise on plasma ammonia and heart rate.
    Hall PE; Smith SR; Kendall MJ
    Clin Sci (Lond); 1987 Jun; 72(6):679-82. PubMed ID: 2885122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of cardioselective and nonselective beta-adrenergic antagonists on pulmonary mechanics.
    Foley JE; Sigurdson MJ; Conliffe TF; Fand RS; Anthonisen NR
    Clin Pharmacol Ther; 1982 Aug; 32(2):149-55. PubMed ID: 6124333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of a cardioselective (metoprolol) and a nonselective (propranolol) beta-adrenergic blocker on the response to dynamic exercise in normal men.
    Sklar J; Johnston GD; Overlie P; Gerber JG; Brammell HL; Gal J; Nies AS
    Circulation; 1982 May; 65(5):894-9. PubMed ID: 7074750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of kinetic interactions of nadolol and propranolol with cimetidine.
    Duchin KL; Stern MA; Willard DA; McKinstry DN
    Am Heart J; 1984 Oct; 108(4 Pt 2):1084-6. PubMed ID: 6148867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of chronic oral cimetidine on apparent liver blood flow and hepatic microsomal enzyme activity in man.
    Daneshmend TK; Ene MD; Parker G; Roberts CJ
    Gut; 1984 Feb; 25(2):125-8. PubMed ID: 6693040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of nadolol and propranolol on plasma lidocaine clearance.
    Schneck DW; Luderer JR; Davis D; Vary J
    Clin Pharmacol Ther; 1984 Nov; 36(5):584-7. PubMed ID: 6488678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of nadolol beta-blockade on blood pressure in hypertension.
    Duchin KL; Vukovich RA; Dennick LG; Groel JT; Willard DA
    Clin Pharmacol Ther; 1980 Jan; 27(1):57-63. PubMed ID: 6101312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma concentrations and beta-blocking effects in normal volunteers after intravenous doses of metoprolol and propranolol.
    Regårdh CG; Johnsson G; Jordö L; Lungborg P; Persson BA; Rönn O
    J Cardiovasc Pharmacol; 1980; 2(6):715-23. PubMed ID: 6160322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Penbutolol and propranolol: a comparison of their effects on antipyrine clearance in man.
    Bax ND; Jones RW; Lennard MS; Tucker GT; Woods HF
    Br J Clin Pharmacol; 1985 May; 19(5):593-6. PubMed ID: 4005101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of beta-adrenoceptor selectivity of a new beta-adrenoceptor antagonist, bisoprolol, in man.
    Tattersfield AE; Cragg DJ; Bacon RJ
    Br J Clin Pharmacol; 1984 Sep; 18(3):343-7. PubMed ID: 6148959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-adrenergic antagonist inhibition of hepatic 3,5,3'-triiodothyronine production.
    Shulkin BL; Peele ME; Utiger RD
    Endocrinology; 1984 Sep; 115(3):858-61. PubMed ID: 6146516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of propranolol, practolol and metoprolol on exercise-induced tachycardia in relation to plasma levels in man.
    Williams FM; Singh BN; Ambler PK; Dorrington R
    Clin Exp Pharmacol Physiol; 1976; 3(5):473-82. PubMed ID: 975632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of atenolol, metoprolol, and propranolol on isoproterenol-induced tremor and tachycardia in normal subjects.
    Perucca E; Pickles H; Richens A
    Clin Pharmacol Ther; 1981 Apr; 29(4):425-33. PubMed ID: 6258838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of antihypertensive agents propranolol, metoprolol, nadolol, prazosin, and chlorthalidone on ACAT activity in rabbit and rat aortas and on LCAT activity in human plasma in vitro.
    Bell FP
    J Cardiovasc Pharmacol; 1985; 7(3):437-42. PubMed ID: 2410671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects on exercise tachycardia during forty-eight hours of a series of doses of atenolol, sotalol, and metoprolol.
    Harron DW; Balnave K; Kinney CD; Wilson R; Russell CJ; Shanks RG
    Clin Pharmacol Ther; 1981 Mar; 29(3):295-302. PubMed ID: 7471600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-adrenoceptor blockade by atenolol, metoprolol and propranolol in the anaesthetized cat.
    Lundgren B; Carlsson E; Herrmann I
    Eur J Pharmacol; 1979 May; 55(3):263-8. PubMed ID: 37096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.